Testing embolization for chronic migraines
Part of Brain & nervous system clinical trials.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with chronic migraine (headaches on 15+ days per month for at least 3 months).
- Your migraines have not responded well to several preventive treatments (refractory).
- You first started having migraines before age 50.
- You do not have other headache disorders (except medication-overuse headache).
- You do not regularly use opioids, cannabis, or medical marijuana.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
This trial tests a new procedure that uses tiny coils to block a specific artery in the head, which may help reduce migraine attacks. It is for people who have tried at least two different preventive migraine medicines without success.
This study tests a procedure that blocks a specific artery in the lining of the brain to see if it can reduce migraine attacks. If you have frequent migraines that haven't improved with medication, this might be a new option worth discussing with your doctor.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
This study tracks patients who get a procedure called middle meningeal artery embolization (a treatment that blocks blood flow to the lining of the brain to help a chronic subdural hematoma heal). The goal is to see how well it works and how patients recover over time.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.